Nextleaf Solutions boosts board with former Health Canada inspector

Nextleaf Solutions Ltd (CSE:OILS) (OTMKTS:OILFF), the extraction technology company, revealed it has added a cannabis regulatory expert and former Health Canada inspector, Sherry Boodram, to its board. 

New director Dr Boodram is the co-founder and CEO of CannDelta Inc – a Toronto-based regulatory and scientific cannabis consulting company.

READ:  Nextleaf Solutions in a consolidation deal with commercialization partner Nextleaf Labs

She provides regulatory expertise and develops strategies to ensure regulatory compliance within Canada’s existing legal cannabis framework.

“The serious regulatory infractions by several large Canadian licensed cannabis producers, along with an expanded scope of cannabis products through legalization 2.0, reinforces the critical role that compliance oversight plays in building a cannabis company all stakeholders can be proud of,” said Paul Pedersen, co-founder and CEO of Nextleaf Solutions.

“Sherry is amongst the most credible and qualified cannabis regulatory experts in Canada, and we believe her background, insights, and industry experience will add tremendous value to our board.”

Before founding CannDelta, Boodram spent several years in the Canadian federal government, notably with Health Canada’s medical cannabis program as a senior regulatory compliance and enforcement officer.

She was responsible for licensing application reviews and on-site facility inspections under the legislative regimes of the Marihuana for Medical Purposes Regulations (MMPR) and Access to Cannabis for Medical Purposes Regulations (ACMPR).

“Being a company with values I can stand behind, I’m very excited to serve alongside Nextleaf’s existing Board members and with their talented executive team,” added Dr Boodram.

Developing IP

Nextleaf Solutions is developing intellectual property (IP) for industrial-scale extraction, purification and formulation of cannabinoids.

It owns a portfolio of eight issued and 35 pending patents related to the production of high-purity, cannabinoid-rich distillate, the key ingredient used in the manufacturing of standardized THC and CBD infused products.

Once cannabis concentrates and edibles become legal across Canada, OILS plans to commercialize its portfolio through IP licensing, B2B processing services, and the supply of THC and CBD oils and concentrates to qualified Canadian and international partners.

Contact the author at [email protected]

Story by ProactiveInvestors